Sharon Fekrat, MD
Department / Division
Ophthalmology /
Retinal Ophthalmology
Address
DUMC 3802
Durham, NC 27710
Appointment Telephone
919-681-3937
Office Telephone
919-684-1857
Fax Telephone
919-681-6474
- MD, University of Chicago Pritzker School of Medicine (Illinois), 1991
- Internal Medicine, Greater Baltimore Medical Center (Maryland), 1991-1992
- Ophthalmology, Wilmer Ophthalmological Institute, Johns Hopkins Medical Institutions (Maryland), 1992-1995
- Medical Retina, Wilmer Ophthalmological Institute, Johns Hopkins Medical Institutions (Maryland), 1995-1996
- Vitreoretinal Surgery, Wilmer Ophthalmological Institute, Johns Hopkins Medical Institutions (Maryland), 1996-1997
- Fellow, American College of Surgeons
Clinical Interests
Complete medical and surgical evaluation and treatment of vitreoretinal diseases including retinal vein occlusion, diabetic retinopathy, macular degeneration, eye trauma, macular holes, epiretinal membranes, retinal detachment, proliferative vitreoretinopathy
Research Interests
Dr.Fekrat's research interests include treatment options for retinal vein occlusion and neovascular age-related macular degeneration. She is investigating new treatment options for these entities that are on the forefront of medical care.
This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Allergan, Inc.
- Pfizer Inc.
Representative Publications
Ahmad S, Bearelly S, Stinnett SS, Cooney MJ, Fekrat S. Photodynamic therapy for predominantly hemorrhagic lesions in neovascular age-related macular degeneration. Am J Ophthalmol. 2008 Jun;145(6):1052-1057.
(2008)
Abstract
Etter J, Fekrat S. Pars plana vitrectomy and internal limiting membrane peeling in an eye with foveal lipid deposition after focal laser surgery for diabetic macular edema. Can J Ophthalmol. 2008 Jun;43(3):373-4.
(2008)
Abstract
Im L, Allingham RR, Singh I, Stinnett S, Fekrat S. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection. J Glaucoma. 2008 Mar;17(2):128-32.
(2008)
Abstract
Melamud A, Stinnett S, Fekrat S. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections. Am J Ophthalmol. 2008 Jul;146(1):91-5.
(2008)
Abstract
Ramchandran RS, Fekrat S, Stinnett SS, Jaffe GJ. Fluocinolone Acetonide Sustained Drug Delivery Device for Chronic Central Retinal Vein Occlusion: 12-Month Results. Am J Ophthalmol. 2008 Jun 2.
(2008)
Abstract
Park CH, Scott AW, Fekrat S. Effect of oral pentoxifylline on cystoid macular edema associated with central retinal vein occlusion. Retina. 2007 Oct;27(8):1020-5.
(2007)
Abstract
Bearelly S, Cooney MJ, Stinnett S, Fekrat S. Intravitreal triamcinolone for cystoid macular edema related to branch retinal vein occlusion. Ann Ophthalmol (Skokie). 2006;38(4):317-20.
(2006)
Abstract
Mahmoud TH, Peng YW, Proia AD, Davidson M, Deramo VA, Fekrat S. Recombinant tissue plasminogen activator injected into the vitreous cavity may penetrate the retinal veins of a porcine model of vascular occlusion. Br J Ophthalmol. 2006 Jul;90(7):911-5.
(2006)
Abstract
Mruthyunjaya P, Wirostko WJ, Chandrashekhar R, Stinnett S, Lai JC, Deramo V, Tang J, Dev S, Postel EA, Connor TB, Fekrat S. Central retinal vein occlusion in patients treated with long-term warfarin sodium (Coumadin) for anticoagulation. Retina. 2006 Mar;26(3):285-91.
(2006)
Abstract
Shuler RK Jr, Fekrat S. Does radial optic neurotomy alter retinal blood flow in eyes with a central retinal vein occlusion? Am J Ophthalmol. 2006 Jan;141(1):145-6.
(2006)
Abstract
Smith BT, Park CH, Fekrat S. Hemi-retinal vein occlusion following LASIK. Ann Ophthalmol (Skokie). 2006;38(2):139-40.
(2006)
Abstract
